Ickler Electric CorporationTM

13250 Kirkham Way Poway, CA 92064 | 858.486.1585

Ionis Pharmaceuticals

Completed in 2012, this ground up facility of 175,000SF delivered in a Design-Assist. The project included R&D laboratories, Vivarium, and corporate Data Center.


Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using its proprietary antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over a dozen drugs in mid- to late-stage development. Drugs currently in Phase 3 development include volanesorsen, a drug Ionis is developing and plans to commercialize through its wholly owned subsidiary, Akcea Therapeutics, to treat patients with familial chylomicronemia syndrome and familial partial lipodystrophy; Ionis-TTRRx, a drug Ionis is developing with GSK to treat patients with all forms of TTR amyloidosis; and nusinersen, a drug Ionis is developing with Biogen to treat children with spinal muscular atrophy.

Click to read more